In the preceding three months, 12 analysts have released ratings for Equifax EFX, presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 8 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 1 | 2 | 0 | 0 | 0 |
2M Ago | 2 | 3 | 0 | 0 | 0 |
3M Ago | 1 | 2 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $325.83, with a high estimate of $375.00 and a low estimate of $283.00. This upward trend is evident, with the current average reflecting a 2.29% increase from the previous average price target of $318.55.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of Equifax by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Toni Kaplan | Morgan Stanley | Raises | Overweight | $320.00 | $275.00 |
Shlomo Rosenbaum | Stifel | Lowers | Buy | $284.00 | $305.00 |
Andrew Steinerman | JP Morgan | Lowers | Overweight | $283.00 | $304.00 |
Owen Lau | Oppenheimer | Lowers | Outperform | $286.00 | $315.00 |
Kyle Peterson | Needham | Maintains | Buy | $350.00 | $350.00 |
Jeffrey Meuler | Baird | Raises | Outperform | $333.00 | $290.00 |
Andrew Steinerman | JP Morgan | Raises | Overweight | $304.00 | $300.00 |
Jason Haas | Wells Fargo | Lowers | Overweight | $350.00 | $375.00 |
Kyle Peterson | Needham | Maintains | Buy | $350.00 | $350.00 |
Owen Lau | Oppenheimer | Raises | Outperform | $315.00 | $300.00 |
Jason Haas | Wells Fargo | Raises | Overweight | $375.00 | $340.00 |
Kevin Mcveigh | UBS | Announces | Buy | $360.00 | - |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Equifax compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Equifax's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Equifax analyst ratings.
About Equifax
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
Financial Insights: Equifax
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Equifax's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 9.3%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's net margin is impressive, surpassing industry averages. With a net margin of 9.8%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.94%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.15%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.11.
The Core of Analyst Ratings: What Every Investor Should Know
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.